Vanguard Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185M | Sell |
8,673,672
-2,966,835
| -25% | -$63.1M | ﹤0.01% | 1542 |
|
|
2025
Q1 | $225M | Sell |
11,640,507
-30,069
| -0.3% | -$580K | ﹤0.01% | 1430 |
|
|
2024
Q4 | $208M | Buy |
11,670,576
+724,040
| +7% | +$12.9M | ﹤0.01% | 1513 |
|
|
2024
Q3 | $240M | Buy |
10,946,536
+2,128,073
| +24% | +$46.6M | ﹤0.01% | 1449 |
|
|
2024
Q2 | $68.8M | Buy |
8,818,463
+1,549,220
| +21% | +$12.1M | ﹤0.01% | 2018 |
|
|
2024
Q1 | $30.1M | Buy |
7,269,243
+254,261
| +4% | +$1.05M | ﹤0.01% | 2394 |
|
|
2023
Q4 | $18.3M | Buy |
7,014,982
+919,307
| +15% | +$2.4M | ﹤0.01% | 2639 |
|
|
2023
Q3 | $11.4M | Sell |
6,095,675
-4,815
| -0.1% | -$9K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $15.3M | Buy |
6,100,490
+4,635,361
| +316% | +$11.6M | ﹤0.01% | 2710 |
|
|
2023
Q1 | $2.56M | Buy |
1,465,129
+21,571
| +1% | +$37.7K | ﹤0.01% | 3587 |
|
|
2022
Q4 | $6.14M | Buy |
1,443,558
+667,636
| +86% | +$2.84M | ﹤0.01% | 3204 |
|
|
2022
Q3 | $923K | Hold |
775,922
| – | – | ﹤0.01% | 4026 |
|
|
2022
Q2 | $776K | Sell |
775,922
-135,474
| -15% | -$135K | ﹤0.01% | 4166 |
|
|
2022
Q1 | $2.23M | Buy |
911,396
+4,509
| +0.5% | +$11K | ﹤0.01% | 3911 |
|
|
2021
Q4 | $2.44M | Buy |
906,887
+1,357
| +0.1% | +$3.65K | ﹤0.01% | 3969 |
|
|
2021
Q3 | $4.54M | Buy |
905,530
+25,632
| +3% | +$128K | ﹤0.01% | 3724 |
|
|
2021
Q2 | $6.56M | Buy |
879,898
+330,356
| +60% | +$2.46M | ﹤0.01% | 3440 |
|
|
2021
Q1 | $3.23M | Hold |
549,542
| – | – | ﹤0.01% | 3734 |
|
|
2020
Q4 | $2.58M | Buy |
+549,542
| New | +$2.58M | ﹤0.01% | 3594 |
|